Matej Štepianský
Matej Štepianský is a public relations specialist at Dôvera, a private health insurance company in Slovakia, who recently addressed the legal challenges surrounding the reimbursement of the medication Voxzogo, which is used to treat achondroplasia. He emphasized that the responsibility for determining which medications are covered by public health insurance lies with the state, not the insurers, and has highlighted the ongoing negotiations between the Ministry of Health and the drug's registration holder to make this treatment accessible to patients in Slovakia.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Slovakia | 2 | 5.00 | 0.14% | +10% | 5,459,642 | 8,204 | $110,000 | 165$ |
| Totals | 2 | 5,459,642 | 8,204 | $110,000 | 165$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Slovakia:
Matej Štepiansky is the PR specialist for Dôvera who expressed the company's intention to negotiate with the hospital.
5
Slovakia:
Matej Štepiansky explained the issues surrounding the processing of ePrescriptions by non-contracted healthcare providers.
5
Slovakia:
Matej Štepiansky is the PR specialist for Dôvera who discussed the ongoing negotiations with the hospital.
5
Slovakia:
Matej Štepianský is a PR specialist for the health insurance company Dôvera.
6